Search Results 111-120 of 9583 for Sulfasalazine

  1. Alefacept (intramuscular route) - Side effects & uses - Mayo Clinic

    Alefacept injection is used to treat chronic plaque psoriasis, which is a skin disease with red and white scales that don't go away. This medicine is given to ...

  2. Pulmonary fibrosis - Symptoms and causes - Mayo Clinic

    Certain anti-inflammatory medicines such as rituximab (Rituxan) or sulfasalazine (Azulfidine) can cause lung damage. Medical conditions. Lung damage can also ...

  3. A Study to Evaluate Baricitinib (LY3009104) to Treat Cutaneous Lichen Planus - Mayo Clinic

    Oral sulfasalazine;; Oral metronidazole;; Systemic immunosuppressant;; Topical treatment. Exclusion Criteria: On excluded therapies, not on a stable dose of a ...

  4. A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor - Mayo Clinic

    Use of oral DMARD (sulfasalazine, hydroxychloroquine, chloroquine and leflunomide) besides MTX must be stable for at least 3 months directly prior to screening ...

  5. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  6. Phosphate Cream In The Treatment Of Cutaneous Lichen Planus - Mayo Clinic

    Oral sulfasalazine;; Oral retinoid. Exclusion Criteria: Subjects fulfilling any of the following criteria are not eligible for inclusion in this study. To ...

  7. https://www.mayoclinic.org/patient_consumer_video.xml

  8. A Study To Evaluate The Effectiveness And Safety Of TD-1473 In Crohn's Disease - Mayo Clinic

    If subject is currently receiving oral aminosalicylate (including, but not limited to sulfasalazine or mesalamine), the subject is eligible provided the ...

  9. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  10. A Study To Evaluate The Effects Of N-Acetyl-L-Leucine For GM2 Gangliosdisosis (Tay-Sachs And Sandhoff Disease) - Mayo Clinic

    Sulfasalazine;; Rosuvastatin. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...